Nyrmalya Bio Engineering Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -274.94%
(FY 2022)
- Ebitda -1067.58%
(FY 2022)
- Net Worth -304.34%
(FY 2022)
- Total Assets 28.36%
(FY 2022)
About Nyrmalya Bio Engineering Solutions
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Devulapalli, Satish Chennamaneni, Shirisha Chennamaneni, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TG2018PTC121852
- Company No.
121852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nyrmalya Bio Engineering Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Devulapalli  | Additional Director | 09-Sep-2020 | Current |
| Satish Chennamaneni | Director | 12-Jan-2018 | Current |
| Shirisha Chennamaneni | Director | 06-Apr-2022 | Current |
| Venkat Bandi | Additional Director | 14-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Nyrmalya Bio Engineering Solutions.
Nyrmalya Bio Engineering Solutions Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 274.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 304.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nyrmalya Bio Engineering Solutions?
In 2021, Nyrmalya Bio Engineering Solutions had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Newgen Utility Solutions Private LimitedActive 13 years 13 days
Satish Chennamaneni is a mutual person
- Chennamaneni Constructions Private LimitedActive 26 years 2 months
Satish Chennamaneni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nyrmalya Bio Engineering Solutions?
Unlock and access historical data on people associated with Nyrmalya Bio Engineering Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyrmalya Bio Engineering Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyrmalya Bio Engineering Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
